IMC:ASX
임뮤론
AU$0.032
0.00%
(0.00) 1D
8월 6일, 오후 1시 46분 50초 GMT+10 · AUD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoIMC의 주요 통계 생성 중...
시가총액
1101.99만
평균 거래량
13.10만
거래량
0.00
52주 최고가
AU$0.10
52주 최저가
AU$0.03
EPS
-AU$0.02
유통 주식수
3.23억
직원 수
7
시가총액
1101.99만
평균 거래량
13.10만
거래량
0.00
52주 최고가
AU$0.10
52주 최저가
AU$0.03
EPS
-AU$0.02
유통 주식수
3.23억
직원 수
7
프로필
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
임뮤론에 관한 정보